Moderna says its decision to remove a paediatric vaccine from Australia was due to stock shortages.
In comments emailed to The Epoch Times, Moderna Australia said that while the country’s pharmaceutical governing body, the Therapeutic Goods Administration, had provisionally approved the drug for use in children less than six years of age, the supply was exhausted.
“In line with current ATAGI guidelines in Australia, Moderna is focused on the ongoing supply of updated and targeted booster vaccines for people aged 12 years and older,” the company said.
“Moderna will continue to engage with vaccine advisory bodies regarding vaccine recommendations for Australians.”…